Opioid Preparedness

ASTHO Opioid Preparedness Webpage

CDC's Opioid Rapid Response Program (ORRP)

Opioid Preparedness Exercise in a Box

Response Protocol Template

How Healthcare Providers Can Reduce Stigma to Improve Care for Patients Taking Long-Term Opioid Therapy

How State Health Departments Can Reduce Stigma to Improve Care for Patients Taking Long-Term Opioid Therapy

Supporting Individuals Experiencing Prescription Controlled Substance Disruptions: A Quick Reference Guide for On-Site Support Personnel | ASTHO

ASTHO Guidebook

Trusted Contacts Training Modules

Exercise Overview

ASTHO Overdose Prevention Webpage

Practices for Coming Back to Equilibrium During a Crisis

Fighting Compassion Fatigue During Public Health Epidemics

ODMAP Overdose Spike Response Framework

NACCHO’s Overdose Spike Response Framework

CSTE Overdose Anomaly Toolkit

Public Health and Safety Team (PHAST) Toolkit

Rethinking Treatment for Patients on Long-Term Opioids

Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids

Assessing reasons for decreased primary care access for... : PAIN

Emergency Department Alternatives to Opioids Program (ED-ALT)

Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder

Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department - PubMed

Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine - PubMed

Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic

Prescribe with Confidence

Model Pharmacist Collaboration for MOUD Act

Dear Registrant MOUD Letter

Doctors' and Pharmacists' Groups Send Joint Letter to DEA, HHS, ONDCP, and SAMHSA on Buprenorphine Access Issues

Barriers to Buprenorphine Dispensing by Medicaid-Participating Community Retail Pharmacies

Independent community pharmacists' attitudes and intentions toward dispensing buprenorphine/naloxone for OUD

Relationships Between Stigma, Risk Tolerance, and Buprenorphine Dispensing Intentions Among Community-Based Pharmacists

Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states

Federal and State Pharmacy Regulations and Dispensing Barriers to Buprenorphine Access at Retail Pharmacies in the US - PubMed

DEA Disconnect Leads to Buprenorphine Bottlenecks - PubMed